1 Min Read
May 1 (Reuters) - Kindred Biosciences Inc
* Kindred Biosciences announces initiation of enrollment in pivotal effectiveness trial of zimeta oral for the control of fever in horses Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.